CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-06 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −2,900 | $194.77 | $565K | 238,383 |
| 2026-03-06 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,600 | $195.80 | $313K | 236,783 |
| 2026-03-06 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,500 | $196.94 | $295K | 235,283 |
| 2026-03-06 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,998 | $198.04 | $396K | 233,285 |
| 2026-03-06 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,598 | 0 | ||
| 2026-03-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Option exercise 10b5-1 | +5,125 | $9.59 | $49K | 153,023 |
| 2026-03-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −931 | $198.83 | $185K | 152,092 |
| 2026-03-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,594 | $200.11 | $319K | 150,498 |
| 2026-03-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −475 | $200.97 | $95K | 150,023 |
| 2026-03-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Option exercise · Stock Option (right to buy) 10b5-1 | −5,125 | 0 | ||
| 2026-03-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,122 | $199.17 | $223K | 159,435 |
| 2026-03-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,463 | $200.24 | $493K | 156,972 |
| 2026-03-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −365 | $201.18 | $73K | 156,607 |
| 2026-03-02 | Sheena Jonathan Director | Sale 10b5-1 | −470 | $198.50 | $93K | 264,794 |
| 2026-03-02 | Sheena Jonathan Director | Sale 10b5-1 | −2,400 | $200.42 | $481K | 262,394 |
| 2026-03-02 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $201.20 | $20K | 262,294 |
| 2026-03-02 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $202.85 | $20K | 262,194 |
| 2026-02-27 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award | +10,051 | 188,132 | ||
| 2026-02-27 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award 10b5-1 | +10,051 | 147,898 | ||
| 2026-02-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Grant or award | +12,272 | 236,085 |
Page 25 of 39 · 767 trades